309 related articles for article (PubMed ID: 29463745)
21. Vital and dispensable roles of Plasmodium multidrug resistance transporters during blood- and mosquito-stage development.
Rijpma SR; van der Velden M; Annoura T; Matz JM; Kenthirapalan S; Kooij TW; Matuschewski K; van Gemert GJ; van de Vegte-Bolmer M; Siebelink-Stoter R; Graumans W; Ramesar J; Klop O; Russel FG; Sauerwein RW; Janse CJ; Franke-Fayard BM; Koenderink JB
Mol Microbiol; 2016 Jul; 101(1):78-91. PubMed ID: 26991313
[TBL] [Abstract][Full Text] [Related]
22. Antiplasmodial and interferon-gamma-modulating activities of the aqueous extract of stone breaker (Phyllanthus niruri Linn.) in malaria infection.
Jeje TO; Bando H; Azad MTA; Fukuda Y; Oluwafemi IE; Kato K
Parasitol Int; 2023 Dec; 97():102789. PubMed ID: 37473798
[TBL] [Abstract][Full Text] [Related]
23. Antiparasitic activities of two sesquiterpenic lactones isolated from Acanthospermum hispidum D.C.
Ganfon H; Bero J; Tchinda AT; Gbaguidi F; Gbenou J; Moudachirou M; Frédérich M; Quetin-Leclercq J
J Ethnopharmacol; 2012 May; 141(1):411-7. PubMed ID: 22440261
[TBL] [Abstract][Full Text] [Related]
24. Pyrazoleamide compounds are potent antimalarials that target Na+ homeostasis in intraerythrocytic Plasmodium falciparum.
Vaidya AB; Morrisey JM; Zhang Z; Das S; Daly TM; Otto TD; Spillman NJ; Wyvratt M; Siegl P; Marfurt J; Wirjanata G; Sebayang BF; Price RN; Chatterjee A; Nagle A; Stasiak M; Charman SA; Angulo-Barturen I; Ferrer S; Belén Jiménez-Díaz M; Martínez MS; Gamo FJ; Avery VM; Ruecker A; Delves M; Kirk K; Berriman M; Kortagere S; Burrows J; Fan E; Bergman LW
Nat Commun; 2014 Nov; 5():5521. PubMed ID: 25422853
[TBL] [Abstract][Full Text] [Related]
25. Further evidence for an anti-inflammatory role of artesunate in experimental cerebral malaria.
Miranda AS; Brant F; Rocha NP; Cisalpino D; Rodrigues DH; Souza DG; Machado FS; Rachid MA; Teixeira AL; Campos AC
Malar J; 2013 Nov; 12():388. PubMed ID: 24180288
[TBL] [Abstract][Full Text] [Related]
26. Spiroindolones, a potent compound class for the treatment of malaria.
Rottmann M; McNamara C; Yeung BK; Lee MC; Zou B; Russell B; Seitz P; Plouffe DM; Dharia NV; Tan J; Cohen SB; Spencer KR; González-Páez GE; Lakshminarayana SB; Goh A; Suwanarusk R; Jegla T; Schmitt EK; Beck HP; Brun R; Nosten F; Renia L; Dartois V; Keller TH; Fidock DA; Winzeler EA; Diagana TT
Science; 2010 Sep; 329(5996):1175-80. PubMed ID: 20813948
[TBL] [Abstract][Full Text] [Related]
27. Cognitive dysfunction is sustained after rescue therapy in experimental cerebral malaria, and is reduced by additive antioxidant therapy.
Reis PA; Comim CM; Hermani F; Silva B; Barichello T; Portella AC; Gomes FC; Sab IM; Frutuoso VS; Oliveira MF; Bozza PT; Bozza FA; Dal-Pizzol F; Zimmerman GA; Quevedo J; Castro-Faria-Neto HC
PLoS Pathog; 2010 Jun; 6(6):e1000963. PubMed ID: 20585569
[TBL] [Abstract][Full Text] [Related]
28. Quantitative characterization of hemozoin in Plasmodium berghei and vivax.
Pisciotta JM; Scholl PF; Shuman JL; Shualev V; Sullivan DJ
Int J Parasitol Drugs Drug Resist; 2017 Apr; 7(1):110-119. PubMed ID: 28279945
[TBL] [Abstract][Full Text] [Related]
29. Effect of α-Tocopheryloxy Acetic Acid on the Infection of Mice with Plasmodium berghei ANKA In Vivo and Humans with P. falciparum In Vitro.
Ariefta NR; Kume A; Nishikawa Y; Taniguchi T; Umemiya-Shirafuji R; Kasai S; Suzuki H
Acta Parasitol; 2022 Dec; 67(4):1514-1520. PubMed ID: 35951222
[TBL] [Abstract][Full Text] [Related]
30. Trafficking of the signature protein of intra-erythrocytic Plasmodium berghei-induced structures, IBIS1, to P. falciparum Maurer's clefts.
Petersen W; Matuschewski K; Ingmundson A
Mol Biochem Parasitol; 2015; 200(1-2):25-9. PubMed ID: 25956941
[TBL] [Abstract][Full Text] [Related]
31. Mycobacterium tuberculosis Coinfection Has No Impact on Plasmodium berghei ANKA-Induced Experimental Cerebral Malaria in C57BL/6 Mice.
Blank J; Behrends J; Jacobs T; Schneider BE
Infect Immun; 2016 Feb; 84(2):502-10. PubMed ID: 26644378
[TBL] [Abstract][Full Text] [Related]
32. Suppression of experimental cerebral malaria by disruption of malate:quinone oxidoreductase.
Niikura M; Komatsuya K; Inoue SI; Matsuda R; Asahi H; Inaoka DK; Kita K; Kobayashi F
Malar J; 2017 Jun; 16(1):247. PubMed ID: 28606087
[TBL] [Abstract][Full Text] [Related]
33. Defibrotide interferes with several steps of the coagulation-inflammation cycle and exhibits therapeutic potential to treat severe malaria.
Francischetti IM; Oliveira CJ; Ostera GR; Yager SB; Debierre-Grockiego F; Carregaro V; Jaramillo-Gutierrez G; Hume JC; Jiang L; Moretz SE; Lin CK; Ribeiro JM; Long CA; Vickers BK; Schwarz RT; Seydel KB; Iacobelli M; Ackerman HC; Srinivasan P; Gomes RB; Wang X; Monteiro RQ; Kotsyfakis M; Sá-Nunes A; Waisberg M
Arterioscler Thromb Vasc Biol; 2012 Mar; 32(3):786-98. PubMed ID: 22116094
[TBL] [Abstract][Full Text] [Related]
34. VEGF and LPS synergistically silence inflammatory response to Plasmodium berghei infection and protect against cerebral malaria.
Canavese M; Dottorini T; Crisanti A
Pathog Glob Health; 2015 Sep; 109(6):255-65. PubMed ID: 26392042
[TBL] [Abstract][Full Text] [Related]
35. Disruption of Parasite hmgb2 Gene Attenuates Plasmodium berghei ANKA Pathogenicity.
Briquet S; Lawson-Hogban N; Boisson B; Soares MP; Péronet R; Smith L; Ménard R; Huerre M; Mécheri S; Vaquero C
Infect Immun; 2015 Jul; 83(7):2771-84. PubMed ID: 25916985
[TBL] [Abstract][Full Text] [Related]
36. The antimicrobial molecule trappin-2/elafin has anti-parasitic properties and is protective in vivo in a murine model of cerebral malaria.
Roussilhon C; Bang G; Bastaert F; Solhonne B; Garcia-Verdugo I; Peronet R; Druilhe P; Sakuntabhai A; Mecheri S; Sallenave JM
Sci Rep; 2017 Feb; 7():42243. PubMed ID: 28181563
[TBL] [Abstract][Full Text] [Related]
37. The effect of nitric oxide on the growth of Plasmodium falciparum, P. chabaudi and P. berghei in vitro.
Balmer P; Phillips HM; Maestre AE; McMonagle FA; Phillips RS
Parasite Immunol; 2000 Feb; 22(2):97-106. PubMed ID: 10652122
[TBL] [Abstract][Full Text] [Related]
38. Host Porphobilinogen Deaminase Deficiency Confers Malaria Resistance in
Schnider CB; Yang H; Starrs L; Ehmann A; Rahimi F; Di Pierro E; Graziadei G; Matthews K; De Koning-Ward T; Bauer DC; Foote SJ; Burgio G; McMorran BJ
Front Cell Infect Microbiol; 2020; 10():464. PubMed ID: 33014890
[TBL] [Abstract][Full Text] [Related]
39. Multidrug ATP-binding cassette transporters are essential for hepatic development of Plasmodium sporozoites.
Rijpma SR; van der Velden M; González-Pons M; Annoura T; van Schaijk BC; van Gemert GJ; van den Heuvel JJ; Ramesar J; Chevalley-Maurel S; Ploemen IH; Khan SM; Franetich JF; Mazier D; de Wilt JH; Serrano AE; Russel FG; Janse CJ; Sauerwein RW; Koenderink JB; Franke-Fayard BM
Cell Microbiol; 2016 Mar; 18(3):369-83. PubMed ID: 26332724
[TBL] [Abstract][Full Text] [Related]
40. Controlled release of artemisone for the treatment of experimental cerebral malaria.
Golenser J; Buchholz V; Bagheri A; Nasereddin A; Dzikowski R; Guo J; Hunt NH; Eyal S; Vakruk N; Greiner A
Parasit Vectors; 2017 Mar; 10(1):117. PubMed ID: 28249591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
